Drupal.behaviors.print = function(context) {window.print();window.close();}>

Signature Dx to Use Affymetrix Chips for Cancer Test Development

June 28, 2010

Signature Dx to Use Affymetrix Chips for Cancer Test Development

Signature Dx will use Affy's microarray technology in two tests it is developing for colorectal cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories